The Manufacturers Life Insurance Company boosted its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 5.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 189,919 shares of the medical equipment provider's stock after purchasing an additional 9,057 shares during the period. The Manufacturers Life Insurance Company owned about 0.57% of Integer worth $24,689,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in the stock. Contravisory Investment Management Inc. boosted its position in shares of Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after buying an additional 80 shares during the period. Huntington National Bank grew its position in Integer by 8,933.3% in the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider's stock valued at $35,000 after acquiring an additional 268 shares in the last quarter. Quest Partners LLC increased its stake in Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider's stock worth $39,000 after purchasing an additional 332 shares during the period. GAMMA Investing LLC increased its stake in Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock worth $43,000 after purchasing an additional 142 shares during the period. Finally, Innealta Capital LLC acquired a new stake in shares of Integer during the second quarter worth about $110,000. Institutional investors and hedge funds own 99.29% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts have commented on ITGR shares. Truist Financial decreased their price target on shares of Integer from $150.00 to $147.00 and set a "buy" rating for the company in a research report on Friday, October 25th. Bank of America upped their price target on Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Tuesday, October 1st. KeyCorp lifted their price objective on Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a research note on Tuesday, October 15th. Benchmark lifted their price target on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Monday, October 21st. Finally, Piper Sandler reissued an "overweight" rating and issued a $140.00 price objective (up from $125.00) on shares of Integer in a research report on Friday, October 25th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, Integer has a consensus rating of "Moderate Buy" and a consensus price target of $139.75.
Read Our Latest Analysis on ITGR
Integer Stock Performance
Shares of NYSE ITGR traded down $0.30 during trading hours on Friday, reaching $140.50. The stock had a trading volume of 149,717 shares, compared to its average volume of 254,823. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. The firm has a market cap of $4.71 billion, a price-to-earnings ratio of 43.36, a PEG ratio of 2.01 and a beta of 1.09. The firm has a 50-day moving average of $131.38 and a 200-day moving average of $124.50. Integer Holdings Co. has a fifty-two week low of $84.75 and a fifty-two week high of $142.00.
Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The company had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. During the same period in the previous year, the business posted $1.27 earnings per share. Integer's quarterly revenue was up 8.7% on a year-over-year basis. Equities research analysts predict that Integer Holdings Co. will post 5.33 earnings per share for the current year.
About Integer
(
Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
See Also
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
